Clinical trial
Prospective Randomized Study Comparing Renal Artery Stenting…
NCT00234585 · University of Toledo Health Science Campus, Other · Completed
Key facts
| NCT number | NCT00234585 |
|---|---|
| Title | Prospective Randomized Study Comparing Renal Artery Stenting (RESIST)With/Without Distal Protection |
| Official title | A Prospective Randomized Multicenter Study Comparing the Safety and Efficacy of Renal Artery Stenting With/Without Distal Protection Device (AngioGuard) and With/Without the Use of a Platelet Aggregator Inhibitor (Abciximab-Reopro) (RESIST) |
| Lead sponsor | University of Toledo Health Science Campus, Other |
| Collaborators | Centocor, Inc. Industry Johnson & Johnson |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Artery Stenosis |
| Intervention type | Device |
| Interventions | Renal Artery Stent with Protective Device/Drug |
| Enrollment | 100 |
| Start date | Aug 1, 2002 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Oct 7, 2005 |
| Last update posted | Dec 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: